Author

H. Vandenplas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

C. Eggermont· 1 shared G. J. Gutierrez· 1 shared J. De Greve· 1 shared M. Noeparast· 1 shared P. Aza-Blanc· 1 shared P. Giron· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Eggermont

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

C. Eggermont, P. Giron, M. Noeparast, H. Vandenplas, P. Aza-Blanc, G. J. Gutierrez, J. De Greve

This study identifies STYK1 as a target that enhances the effects of EGFR inhibition in NSCLC cells, suggesting co-targeting EGFR and STYK1 may improve treatment outcomes.

bioRxiv · Apr 26, 2022Cancer Biology